Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 364

1.

NK cell-based therapeutics for lung cancer.

Pockley AG, Vaupel P, Multhoff G.

Expert Opin Biol Ther. 2019 Nov 12:1-11. doi: 10.1080/14712598.2020.1688298. [Epub ahead of print]

PMID:
31714156
2.

Thermal field formation during wIRA-hyperthermia: temperature measurements in skin and subcutis of piglets as a basis for thermotherapy of superficial tumors and local skin infections caused by thermosensitive microbial pathogens.

Piazena H, Müller W, Pendl W, von Ah S, Cap VH, Hug PJ, Sidler X, Pluschke G, Vaupel P.

Int J Hyperthermia. 2019;36(1):938-952. doi: 10.1080/02656736.2019.1655594.

PMID:
31535588
3.

The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.

Vaupel P, Schmidberger H, Mayer A.

Int J Radiat Biol. 2019 Jul;95(7):912-919. doi: 10.1080/09553002.2019.1589653. Epub 2019 Mar 22.

PMID:
30822194
4.

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study.

Kokowski K, Stangl S, Seier S, Hildebrandt M, Vaupel P, Multhoff G.

Strahlenther Onkol. 2019 Apr;195(4):352-361. doi: 10.1007/s00066-019-01434-9. Epub 2019 Feb 11.

5.

Impact of Temporal Heterogeneity of Acute Hypoxia on the Radiation Response of Experimental Tumors.

Xu L, Vaupel P, Menze BH, Shi K.

Adv Exp Med Biol. 2018;1072:189-194. doi: 10.1007/978-3-319-91287-5_30.

PMID:
30178344
6.

Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.

Vaupel P, Multhoff G.

Adv Exp Med Biol. 2018;1072:171-175. doi: 10.1007/978-3-319-91287-5_27. Review.

PMID:
30178341
7.

Biophysical and photobiological basics of water-filtered infrared-A hyperthermia of superficial tumors.

Vaupel P, Piazena H, Müller W, Notter M.

Int J Hyperthermia. 2018;35(1):26-36. doi: 10.1080/02656736.2018.1469169. Epub 2018 May 10. Review.

PMID:
29745269
8.
9.

Master of Science (MSc) Program in Radiation Biology: An Interdepartmental Course Bridging the Gap between Radiation-Related Preclinical and Clinical Disciplines to Prepare Next-Generation Medical Scientists.

Combs SE, Kessel C, Wilkens JJ, Multhoff G, Schmid TE, Vaupel P, Trott KR, Berberat P, Atkinson MJ.

Front Oncol. 2017 Sep 22;7:226. doi: 10.3389/fonc.2017.00226. eCollection 2017.

10.

Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis.

Metzger JC, Wollschläger D, Miederer M, Vaupel P, Moehler M, Schmidberger H, Mayer A.

Strahlenther Onkol. 2017 Oct;193(10):791-799. doi: 10.1007/s00066-017-1164-3. Epub 2017 Aug 2.

PMID:
28770295
11.

Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?

Peeken JC, Vaupel P, Combs SE.

Front Oncol. 2017 Jun 30;7:132. doi: 10.3389/fonc.2017.00132. eCollection 2017. Review.

12.

ESPEN expert group recommendations for action against cancer-related malnutrition.

Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, Erickson N, Laviano A, Lisanti MP, Lobo DN, McMillan DC, Muscaritoli M, Ockenga J, Pirlich M, Strasser F, de van der Schueren M, Van Gossum A, Vaupel P, Weimann A.

Clin Nutr. 2017 Oct;36(5):1187-1196. doi: 10.1016/j.clnu.2017.06.017. Epub 2017 Jun 23. Review.

PMID:
28689670
13.

Computational Simulation of Tumor Hypoxia Based on In Vivo Microvasculature Assessed in a Dorsal Skin Window Chamber.

Xu L, Vaupel P, Bai S, Menze B, Shi K.

Adv Exp Med Biol. 2017;977:109-117. doi: 10.1007/978-3-319-55231-6_15.

PMID:
28685434
14.

Multiparametric Analysis of the Tumor Microenvironment: Hypoxia Markers and Beyond.

Mayer A, Vaupel P.

Adv Exp Med Biol. 2017;977:101-107. doi: 10.1007/978-3-319-55231-6_14. Review.

PMID:
28685433
15.

Tumor Oxygenation Status: Facts and Fallacies.

Vaupel P, Mayer A.

Adv Exp Med Biol. 2017;977:91-99. doi: 10.1007/978-3-319-55231-6_13. Review.

PMID:
28685432
16.

Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.

Hoppe-Seyler K, Bossler F, Lohrey C, Bulkescher J, Rösl F, Jansen L, Mayer A, Vaupel P, Dürst M, Hoppe-Seyler F.

Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E990-E998. doi: 10.1073/pnas.1615758114. Epub 2017 Jan 23.

17.

Matching the reaction-diffusion simulation to dynamic [18F]FMISO PET measurements in tumors: extension to a flow-limited oxygen-dependent model.

Shi K, Bayer C, Gaertner FC, Astner ST, Wilkens JJ, Nüsslin F, Vaupel P, Ziegler SI.

Physiol Meas. 2017 Feb;38(2):188-204. doi: 10.1088/1361-6579/aa5071. Epub 2017 Jan 5.

PMID:
28055983
18.

Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck.

Mayer A, Zahnreich S, Brieger J, Vaupel P, Schmidberger H.

Br J Cancer. 2016 Nov 22;115(11):1351-1358. doi: 10.1038/bjc.2016.336. Epub 2016 Nov 1.

19.

Commentary: A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment.

Vaupel P, Multhoff G.

Front Immunol. 2016 Aug 31;7:332. doi: 10.3389/fimmu.2016.00332. eCollection 2016. No abstract available.

20.

Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients.

Notter M, Piazena H, Vaupel P.

Int J Hyperthermia. 2017 Mar;33(2):227-236. doi: 10.1080/02656736.2016.1235731. Epub 2016 Sep 28.

PMID:
27618745
21.

Molecular Imaging of Tumor Hypoxia: Existing Problems and Their Potential Model-Based Solutions.

Shi K, Ziegler SI, Vaupel P.

Adv Exp Med Biol. 2016;923:87-93. doi: 10.1007/978-3-319-38810-6_12.

PMID:
27526129
22.

Tumor Hypoxia: Causative Mechanisms, Microregional Heterogeneities, and the Role of Tissue-Based Hypoxia Markers.

Vaupel P, Mayer A.

Adv Exp Med Biol. 2016;923:77-86. doi: 10.1007/978-3-319-38810-6_11. Review.

PMID:
27526128
23.

Quantitative Analysis of [18F]FMISO PET for Tumor Hypoxia: Correlation of Modeling Results with Immunohistochemistry.

Shi K, Bayer C, Astner ST, Gaertner FC, Vaupel P, Schwaiger M, Huang SC, Ziegler SI.

Mol Imaging Biol. 2017 Feb;19(1):120-129. doi: 10.1007/s11307-016-0975-4.

PMID:
27379986
24.

Pathophysiological Basis for the Formation of the Tumor Microenvironment.

Horsman MR, Vaupel P.

Front Oncol. 2016 Apr 12;6:66. doi: 10.3389/fonc.2016.00066. eCollection 2016. Review.

25.

Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.

Vaupel P, Multhoff G.

Strahlenther Onkol. 2016 May;192(5):279-87. doi: 10.1007/s00066-016-0948-1. Epub 2016 Mar 9. Review.

PMID:
26961686
26.

Hypoxia-Associated Marker CA IX Does Not Predict the Response of Locally Advanced Rectal Cancers to Neoadjuvant Chemoradiotherapy.

Mayer A, Vaupel P, Oberholzer K, Ebert M, Dimitrow M, Kreft A, Mueller-Klieser W, Schmidberger H.

Adv Exp Med Biol. 2016;876:195-200. doi: 10.1007/978-1-4939-3023-4_24.

PMID:
26782212
27.

Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression.

Vaupel P, Mayer A.

Adv Exp Med Biol. 2016;876:177-183. doi: 10.1007/978-1-4939-3023-4_22.

PMID:
26782210
28.

Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts.

Combs SE, Schmid TE, Vaupel P, Multhoff G.

Cancers (Basel). 2016 Jan 13;8(1). pii: E15. doi: 10.3390/cancers8010015. Review.

29.

Can respiratory hyperoxia mitigate adenosine-driven suppression of antitumor immunity?

Vaupel P, Mayer A.

Ann Transl Med. 2015 Nov;3(19):292. doi: 10.3978/j.issn.2305-5839.2015.09.23. No abstract available.

30.

Temporal changes in tumor oxygenation and perfusion upon normo- and hyperbaric inspiratory hyperoxia.

Thews O, Vaupel P.

Strahlenther Onkol. 2016 Mar;192(3):174-81. doi: 10.1007/s00066-015-0916-1. Epub 2015 Oct 26.

PMID:
26501141
31.

Spatial oxygenation profiles in tumors during normo- and hyperbaric hyperoxia.

Thews O, Vaupel P.

Strahlenther Onkol. 2015 Nov;191(11):875-82. doi: 10.1007/s00066-015-0867-6. Epub 2015 Jul 2.

PMID:
26135917
32.

Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.

Mayer A, Schwanbeck C, Sommer C, Stockinger M, Giese A, Renovanz M, Vaupel P, Schmidberger H.

Strahlenther Onkol. 2015 Aug;191(8):665-71. doi: 10.1007/s00066-015-0855-x. Epub 2015 May 30.

PMID:
26025143
33.

Exploring the quantitative relationship between metabolism and enzymatic phenotype by physiological modeling of glucose metabolism and lactate oxidation in solid tumors.

Wang Q, Vaupel P, Ziegler SI, Shi K.

Phys Med Biol. 2015 Mar 21;60(6):2547-71. doi: 10.1088/0031-9155/60/6/2547. Epub 2015 Mar 12.

PMID:
25761504
34.

Response to commentary by Champ and Klement: Is a ketogenic diet the solution for the hyperglycemia problem in glioblastoma therapy?

Mayer A, Vaupel P, Struss HG, Giese A, Stockinger M, Schmidberger H.

Strahlenther Onkol. 2015 Mar;191(3):283-4. doi: 10.1007/s00066-014-0793-z. No abstract available.

PMID:
25595495
35.

The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Vaupel P, Mayer A.

Antioxid Redox Signal. 2015 Apr 1;22(10):878-80. doi: 10.1089/ars.2014.6155. Epub 2014 Dec 10. No abstract available.

PMID:
25340660
36.

GLUT-1 expression is largely unrelated to both hypoxia and the Warburg phenotype in squamous cell carcinomas of the vulva.

Mayer A, Schmidt M, Seeger A, Serras AF, Vaupel P, Schmidberger H.

BMC Cancer. 2014 Oct 12;14:760. doi: 10.1186/1471-2407-14-760.

37.

Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme.

Mayer A, Vaupel P, Struss HG, Giese A, Stockinger M, Schmidberger H.

Strahlenther Onkol. 2014 Oct;190(10):933-8. doi: 10.1007/s00066-014-0696-z. Epub 2014 Jun 18.

PMID:
24938515
38.

Heterogeneity in tissue oxygenation: from physiological variability in normal tissues to pathophysiological chaos in malignant tumours.

Harrison DK, Vaupel P.

Adv Exp Med Biol. 2014;812:25-31. doi: 10.1007/978-1-4939-0620-8_4.

PMID:
24729211
39.

Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications.

Vaupel P, Mayer A.

Adv Exp Med Biol. 2014;812:19-24. doi: 10.1007/978-1-4939-0620-8_3. Review.

PMID:
24729210
40.

Critical role of aberrant angiogenesis in the development of tumor hypoxia and associated radioresistance.

Multhoff G, Radons J, Vaupel P.

Cancers (Basel). 2014 Apr 8;6(2):813-28. doi: 10.3390/cancers6020813.

41.

Preclinical evaluation of parametric image reconstruction of [18F]FMISO PET: correlation with ex vivo immunohistochemistry.

Cheng X, Bayer C, Maftei CA, Astner ST, Vaupel P, Ziegler SI, Shi K.

Phys Med Biol. 2014 Jan 20;59(2):347-62. doi: 10.1088/0031-9155/59/2/347. Epub 2013 Dec 19.

PMID:
24351879
42.

Tumor oxygenation: an appraisal of past and present concepts and a look into the future : Arisztid G. B. Kovách Lecture.

Vaupel P.

Adv Exp Med Biol. 2013;789:229-236. doi: 10.1007/978-1-4614-7411-1_31.

PMID:
23852499
43.

Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy?

Mayer A, Vaupel P.

Adv Exp Med Biol. 2013;789:203-209. doi: 10.1007/978-1-4614-7411-1_28. Review.

PMID:
23852496
44.

Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix.

Mayer A, Höckel M, Schlischewsky N, Schmidberger H, Horn LC, Vaupel P.

Br J Cancer. 2013 Feb 5;108(2):402-8. doi: 10.1038/bjc.2012.570. Epub 2013 Jan 15.

45.
46.

[Tumor pathophysiology].

Kunz-Schughart LA, Mueller-Klieser W, Vaupel P.

Strahlenther Onkol. 2012 Nov;188 Suppl 3:299-303. doi: 10.1007/s00066-012-0203-3. Review. German. No abstract available.

PMID:
23053151
47.

Blood flow and oxygenation status of prostate cancers.

Vaupel P, Kelleher DK.

Adv Exp Med Biol. 2013;765:299-305. doi: 10.1007/978-1-4614-4989-8_42.

PMID:
22879048
48.

Blood flow and associated pathophysiology of uterine cervix cancers: characterisation and relevance for localised hyperthermia.

Vaupel PW, Kelleher DK.

Int J Hyperthermia. 2012;28(6):518-27. doi: 10.3109/02656736.2012.699134. Epub 2012 Jul 27. Review.

PMID:
22838732
49.

Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.

Mayer A, Schneider F, Vaupel P, Sommer C, Schmidberger H.

Int J Oncol. 2012 Oct;41(4):1260-70. doi: 10.3892/ijo.2012.1555. Epub 2012 Jul 16.

50.

Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas. Detection and quantification using (immuno-)fluorescence techniques.

Maftei CA, Bayer C, Shi K, Vaupel P.

Strahlenther Onkol. 2012 Jul;188(7):606-15. doi: 10.1007/s00066-012-0105-4. Epub 2012 Jun 14.

PMID:
22695745

Supplemental Content

Loading ...
Support Center